Hoechst Pakistan

Hoechst Pakistan Limited is a leading pharmaceutical company based in Karachi, Pakistan, with a legacy spanning over five decades. Formerly known as Sanofi-Aventis Pakistan Limited, the company reverted to its original name in 2023 after a consortium led by the Packages Group acquired the majority stake from Sanofi. The company specializes in the manufacturing, marketing, and distribution of a wide range of pharmaceutical products under license, including essential treatments for diabetes, cardiology, and central nervous system disorders. Its portfolio features globally recognized brands such as Lantus, Flagyl, and Amaryl. Hoechst Pakistan operates a large-scale, GMP-compliant manufacturing facility and maintains an extensive distribution network to serve the healthcare needs of the Pakistani population.